Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11332533 Modified antibody constant region

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

June 6, 2017

Date of Patent

May 17, 2022

Patent Application Number

15614842

Patent Citations

US Patent 10066018 Antibody constant region variant

US Patent 10150808 Modified antibody constant regions

US Patent 10253091 Antibody constant region variant

US Patent 10435458 Antibody constant region variants with reduced Fcgammar binding

US Patent 10604561 Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

US Patent 10662245 Methods of reducing IL-6 activity for disease treatment

US Patent 10844113 Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

US Patent 10774148 Composition for treating IL-6-related diseases

US Patent 11046784 Methods for controlling blood pharmacokinetics of antibodies

US Patent 10934344 Methods of modifying antibodies for purification of bispecific antibodies

•••

Patent Citations Received

US Patent 12122840 Method of modifying isoelectric point of antibody via amino acid substitution in CDR

0

US Patent 11891432 Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of use

0

US Patent 12116414 Method of modifying isoelectric point of antibody via amino acid substitution in CDR

0

US Patent 11649262 Method for promoting efficiency of purification of Fc region-containing polypeptide

0

US Patent 11780908 Anti-dengue virus antibodies, polypeptides containing variant FC regions, and methods of use

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Find more entities like US Patent 11332533 Modified antibody constant region

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool